|
|
|
|
RCTs intensive versus standard glycaemic
|
|
|
|
diabetes & vascular disease
|
|
|
|
Diabetes CV guidance
|
|
|
|
Pathogenesis of Hyperglycaemia
|
|
|
|
Glucagon –like Peptide 1 (GLP1)
|
|
|
|
Insulin Secretion Cellular Processes
|
|
|
|
DPP4 - EASD Lisbon
|
|
|
|
Insulin Secretion in the Beta Cell
|
|
|
|
TAK-875 or glimepiride
|
|
|
|
TAK-875 or glimepiride
|
|
|
|
PPAR alpha and gamma
|
|
|
|
Benefits of Pioglitazone: Lipid Metabolism
|
|
|
|
HDL may promote reverse..
|
|
|
|
Aleglitazar, Fenofibric Acid and Pioglitazone
|
|
|
|
SYNCHRONY - Effects of Aleglitazar
|
|
|
|
SYNCHRONY - Aleglitazar -Lipids
|
|
|
|
Aleglitazar – ALECARDIO
|
|
Share this page with your colleagues and friends: